Mineralocorticoid Antagonism and Diabetic Kidney Disease by Lytvyn, Yuliya, Godoy, Lucas C., Scholtes, Rosalie A., van Raalte, Daniël H., Cherney, David Z.

Get full text

Exposure-Response Analysis of the Sodium-Glucose Cotransporter-2 Inhibitors Dapagliflozin and Empagliflozin on Kidney Hemodynamics in Patients with Type 2 Diabetes by van der Hoek, Sjoukje, Koomen, Jeroen V, van Bommel, Erik J M, Mosterd, Charlotte M, Scholtes, Rosalie A, Hesp, Anne C, Stevens, Jasper, van Raalte, Daniel H, Heerspink, Hiddo J L

Get full text

Kidney Hemodynamic Effects of Angiotensin Receptor Blockade, Sodium-Glucose Cotransporter-2 Inhibition Alone, and Their Combination: A Crossover Randomized Trial in People With Typ... by Scholtes, Rosalie A., Hesp, Anne C., Mosterd, Charlotte M., Geurts, Frank, Hoorn, Ewout J., Touw, Daan J., Krebber, Merle M., Joles, Jaap A., Heerspink, Hiddo J.L., van Raalte, Daniël H.

Get full text

Mechanisms underlying the blood pressure‐lowering effects of empagliflozin, losartan and their combination in people with type 2 diabetes: A secondary analysis of a randomized cros... by Scholtes, Rosalie A., Mosterd, Charlotte M., Hesp, Anne C., Smits, Mark M., Heerspink, Hiddo J. L., Raalte, Daniël H.

Get full text

Sodium glucose cotransporter (SGLT)‐2 inhibitors: Do we need them for glucose‐lowering, for cardiorenal protection or both? by Scholtes, Rosalie A., Baar, Michaël J. B., Lytvyn, Yuliya, Bjornstad, Petter, Nieuwdorp, Max, Cherney, David Z. I., Raalte, Daniël H.

Get full text

The effects of dapagliflozin on cardio‐renal risk factors in patients with type 2 diabetes with or without renin‐angiotensin system inhibitor treatment: a post hoc analysis by Scholtes, Rosalie A., Raalte, Daniël H., Correa‐Rotter, Ricardo, Toto, Robert D., Heerspink, Hiddo J. L., Cain, Valerie, Sjöström, C. David, Sartipy, Peter, Stefánsson, Bergur V.

Get full text

Renal haemodynamic and protective effects of renoactive drugs in type 2 diabetes: Interaction with SGLT2 inhibitors by Scholtes, Rosalie A., Baar, Michaël J. B., Kok, Megan D., Bjornstad, Petter, Cherney, David Z. I., Joles, Jaap A., Raalte, Daniël H.

Get full text

The Adaptive Renal Response for Volume Homeostasis During 2 Weeks of Dapagliflozin Treatment in People With Type 2 Diabetes and Preserved Renal Function on a Sodium-Controlled Diet... by Scholtes, Rosalie A., Muskiet, Marcel H.A., van Baar, Michiel J.B., Hesp, Anne C., Greasley, Peter J., Hammarstedt, Ann, Karlsson, Cecilia, Hallow, Karen M., Danser, A.H. Jan, Heerspink, Hiddo J.L., van Raalte, Daniël H.

Get full text

Glucosuria Interferes With Measurement of Effective Renal Plasma Flow Using para-Aminohippuric Acid, With a Focus on SGLT2 Inhibitors by Scholtes, Rosalie A., Nguyen, Isabel T.N., van Bommel, Erik J.M., Willekes, Nel, van Nieuwenhuijzen, Melanie, van Raalte, Daniël H., Joles, Jaap A.

Get full text

Effects of dapagliflozin on volume status and systemic haemodynamics in patients with chronic kidney disease without diabetes: Results from DAPASALT and DIAMOND by Sen, Taha, Scholtes, Rosalie, Greasley, Peter J., Cherney, David Z. I., Dekkers, Claire C. J., Vervloet, Marc, Danser, Alexander H. J., Barbour, Sean J., Karlsson, Cecilia, Hammarstedt, Ann, Li, Qiang, Laverman, Gozewijn D., Bjornstad, Petter, Raalte, Daniel H., Heerspink, Hiddo J. L.

Get full text